China is interested in buying medicines from India

China, known as world's manufacturing powerhouse, is moving fast towards a more value-add economy and there is one big industry where the country could dominate the market both as a maker and consumer: healthcare industry.

That is because, in a matter of decades, China rocketed into its position as the world's second-largest economy under a strict one-child policy, contributing to a rapidly aging society with rising there needs.

The pharmaceutical industry is one of the leading industries in China. It is covering synthetic drugs and chemicals, medical devices, hygiene materials, prepared Chinese medicines, pharmaceutical machinery, apparatus and instruments, and packing materials.

According to health-care information company (IQVIA), China was the world's second-largest national pharmaceutical market in 2017 — it was worth 122.6 billion US Dollars. It was also the biggest emerging business market for pharmaceuticals with growth gained from $145 billion to $175 billion by 2022.


China showed interest in buying drugs from India

Chinese officials from Guiyang city expressed their interest in buying medicines form Indian pharmaceutical companies and invited to Guiyang city to discuss on the modalities and issues concerning India's export of medicines to the Chinese markets.

The Pharmexcil has invited pharmaceutical companies of India to utilize this export opportunity to supply the drugs to the Chinese market. It is a long-term opportunity for Indian pharmaceutical companies to sustain a long-term export business.

The committee along with the Indian embassy in China and the department of commerce, government of India were actively working hard with the Chinese government to organize a meeting in Guiyang city which was held on 18-19 October 2018.

When this export opportunity was informed by the Uday Bhaskar, director general of Pharmexcil said:

"Based on our continuous supplication with the Chinese government on various occasions, we have received a communication from the Indian embassy stating that the Guiyang province is interested in buying medicines from Indian companies. This is a great opportunity for the Indian pharmaceutical companies to venture into the Chinese markets."

Below is the letter by Uday Bhaskar, director general of Pharmexcil informing Indian pharmaceutical companies to take this opportunity.






Customs clearance is an important document that should be obtained when you want to export medicines to China.

You can get by yourself or hire a customs clearance agent. Generate online shipping bill electronically. Thus, the material is moved to the shipping area where custom experts inspect it.

Custom clearance department issues ‘Let Export Order' which means that the shipping bill can be printed.



Government has banned 328 FDC

The Government has banned 328 FDC

FDC ban effect
Source: AIOCD PharmaTrac

The Health Ministry has banned the manufacture, sale, and distribution of 328 Fixed Dose Combination (FDC) drugs with an immediate effect on September 12, 2018. The Indian pharmaceutical market size is estimated at around Rs 1.18-1.2 lakh crore, and FDCs reportedly make up approximately 50% of the sales. Here's what you need to know about them:

FDC means a combination of two or more drugs in a fixed dosage ratio. Some of the 328 banned FDC were: Cefixime + Azithromycin, Metronidazole + Norfloxacin, and Paracetamol + Propyphenazone + Caffeine (trade name Saridon), Ofloxacin + Ornidazole Suspension.

Why FDCs are so popular?

The simple answer to this question is cost. It is very cheap to buy Fixed dosage combination. Instead of buying two or more different medicines, a patient can buy only one FDC medicine to treat multiple disease symptoms. Pharmaceutical companies love them because it is far cheaper and quicker to combine existing active ingredients to manufacture new products than to discover new medicines and manufacture them separately.

Why has the government banned them?

The central government took this decision after the Drugs Technical Advisory Board recommended that "there is no therapeutic justification" for the ingredients contained in the banned 328 FDC drugs and that these medicines may involve risk to the patient.

Also, All India Drug Action Network (AIDAN), a network of NGOs that work to increase accessibility and improve the usage of essential medicines, said the people have been supplied with non-standard medicines for long.




How was Vibcare Pharma affected?

None of our products were affected by this ban on FDC. Do check our complete products list.

Here is a complete list of the banned drugs:

Reference : National Health Portal